New imaging techniques to analyze the front part of the eye for glaucoma
Novel ocular imaging and molecular analysis of anterior eye segment for glaucoma
This study is looking at how glaucoma affects the eye and aims to create better imaging techniques to see how fluid drains from the eye, which is important for keeping eye pressure in check, so that new treatments can be developed to help people with glaucoma.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11042737 on NIH RePORTER |
What this research studies
This research focuses on understanding glaucoma, a leading cause of irreversible blindness, by investigating the anterior segment of the eye. It aims to develop advanced imaging techniques to visualize the drainage pathways of aqueous humor, which is crucial for managing intraocular pressure (IOP). By studying the unique cells in Schlemm's canal and the signaling pathways involved, the research seeks to uncover the mechanisms that lead to increased IOP and ultimately, glaucoma. Patients may benefit from new therapeutic approaches that arise from these findings.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with glaucoma, particularly those experiencing elevated intraocular pressure.
Not a fit: Patients with other eye conditions unrelated to glaucoma may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for glaucoma, potentially reducing the risk of blindness.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for ocular conditions, suggesting that this approach could yield significant insights.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Kume, Tsutomu — Northwestern University at Chicago
- Study coordinator: Kume, Tsutomu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.